Biogen Inc (NASDAQ: BIIB)

DRUGS - Biotechnology
Sector: Health Care

Stock price data as of 07/01/2022

Closing price: 210.63

Support price level:	$195.84
Resistance price level:	$214.09
Relative strength index (14-day RSI)	60.9
Beta	0.89

With a -39.6 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.
BIIB is one of this month's top performers with a return of 6.1 percent, beating 90 percent of stocks in the S&P-100.
Volatility is forecast to rise over the next month.

Low	High	Price as % of Range
$187.54	$369.05	17.2%

200 day	50 day	20 day	10 day
$230.16	$202.36	$202.76	$207.48

(Annualized standard deviation)

Historical (5 year)	Last month	Current estimate	Next month forecast
44.3%	39.4%	40.6%	46.9%

There is an estimated 5% probability that the stock price of Biogen Inc will fall by more than: